NUVAXOVID

This brand name is authorized in Australia, Austria, Croatia, Estonia, Finland, France, Ireland, Italy, Japan, Lithuania, New Zealand, Poland, Romania, Spain, UK.

Active ingredients

The drug NUVAXOVID contains one active pharmaceutical ingredient (API):

1	SARS-CoV-2 protein subunit vaccine (NVX-CoV2373) UNII UK9AK2IN1P - NVX-COV2373
	SARS-CoV-2 protein subunit vaccine (NVX-CoV2373) is composed of purified full-length SARS-CoV-2 recombinant spike (S) protein that is stabilised in its prefusion conformation. The addition of the saponin-based Matrix-M adjuvant facilitates activation of the cells of the innate immune system, which enhances the magnitude of the S protein-specific immune response. The two vaccine components elicit B- and T-cell immune responses to the S protein, including neutralising antibodies, which may contribute to protection against COVID-19.
	Read more about SARS-CoV-2 protein subunit vaccine (NVX-CoV2373)

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
NUVAXOVID Dispersion for injection	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J07BN04		J Antiinfectives for systemic use → J07 Vaccines → J07B Viral vaccines → J07BN Covid-19 vaccines
Discover more medicines within J07BN04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1868081
ES	Centro de información online de medicamentos de la AEMPS	1211618001, 1211618008
FI	Lääkealan turvallisuus- ja kehittämiskeskus	152354
FR	Base de données publique des médicaments	65689785, 69544189
IT	Agenzia del Farmaco	049811019, 049811021, 049811033, 049811045, 050926017, 050926029
JP	医薬品医療機器総合機構	631341GA1029
LT	Valstybinė vaistų kontrolės tarnyba	1093886, 1096834, 1097303, 1097304, 1098021, 1098022
NZ	Medicines and Medical Devices Safety Authority	22259
PL	Rejestru Produktów Leczniczych	100462131
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W68339001